引导式测验 · 中等 等级

人工智能在药物安全和药物警戒测验中的应用

审查跨产品药品安全监测工作流程中的不良事件报告、信号检测和标准化编码。

相关引导路径人工智能在药物安全和药物警戒中的应用
问题 1 的 8

药物警戒的主要目标是什么？

预览每个问题8 问题

当您参加测验时，就会出现答案和解释。

  1. 药物警戒的主要目标是什么？
    • 检测、评估和预防药物使用后的危害
    • 向医生推销新药
    • 设定药品零售价
    • 设计药丸包装
  2. In the published n2c2 clinical NLP system, what information did the system extract from narrative notes?
    • Only patients’ handwritten signatures
    • Medication and adverse-event concepts and their relations
    • Only final regulatory decisions
    • Only medicine prices
  3. 不成比例分析在不良事件数据库中检测到什么？
    • 品牌药和仿制药之间的价格差异
    • 哪家医院提交的报告最多
    • 药物事件对的报告频率比统计概率预测的要高
    • 药物的有效期
  4. What is VigiBase, according to Uppsala Monitoring Centre?
    • A database of randomized clinical-trial efficacy results only
    • A list of confirmed causal side effects for every medicine
    • A commercial catalogue of approved drug prices
    • The WHO global database of reported adverse events for medicines and vaccines
  5. MedDRA 在药物警戒管道中的用途是什么？
    • 用于编码反应和状况的标准化医学词汇
    • 某医药包装品牌
    • 专为医生设计的日程安排应用程序
    • 一种 MRI 扫描仪
  6. Which sequence does UMC describe in its signal-management process?
    • Diagnosis, prescription, dispensing, billing and discharge
    • Detection, validation, prioritisation, assessment and communication
    • Data collection, automatic causality decision, recall and litigation
    • Model training, deployment, billing and marketing
  7. How should a high disproportionality score in a spontaneous-report database be interpreted?
    • As a population incidence rate for all patients
    • As a confirmed causal adverse reaction
    • As a statistical signal for further assessment, not proof that the drug caused the event
    • As proof that no other factor contributed
  8. Which four elements satisfy the minimum ICSR criteria in ICH E2D(R1)?
    • A confirmed causal link, a batch number, a prescriber signature, and a laboratory result
    • A product label, a randomized trial, a treatment response, and a safety committee vote
    • A hospital admission, a known dose, a genetic profile, and a published case report
    • An adverse event or other observation, a suspect or interacting product, an identifiable patient, and an identifiable reporter